{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:46:20Z","timestamp":1793119580945,"version":"4.5.0"},"reference-count":51,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2800,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1529-8019.2008.00172.x","type":"journal-article","created":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T00:25:22Z","timestamp":1204676722000},"page":"69-82","source":"Crossref","is-referenced-by-count":19,"title":["Psychopharmacology in dermatology"],"prefix":"10.1155","volume":"21","author":[{"given":"Chai Sue","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Accordino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"b1_208","doi-asserted-by":"crossref","unstructured":"1.JT Haskins, L Aguilar, A Pallay, and for the Venalafaxine XR 210 Study Group , et al. Double-blind, placebo-controlled study of once daily venlafaxine XR in outpatients with generalized anxiety disorder [abstract ]. Presented at the 11th Congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80465-3"},{"key":"b2_209","doi-asserted-by":"crossref","unstructured":"2.JT Haskins, R Rudolph, L Aguiar, and for the Venlafaxine XR 214 Study Group , et al. Double-blind, placebo-comparator-controlled study of once daily venlafaxine XR and buspirone in outpatients with generalized anxiety disorder [abstract] . Presented at the 11th Congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80465-3"},{"key":"b3_210","doi-asserted-by":"crossref","unstructured":"3.JT Haskins, R Rudolph, L Aguiar, and for the Venlafaxine XR 218 Study Group , et al. Venlafaxine XR is an efficacious short- and long-term treatment for generalized anxiety disorder [abstract] . Presented at the 11th Congress of the European College of Neuropychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80488-4"},{"key":"b4_211","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4088\/JCP.v62n0508","volume":"62","author":"Pollack MH","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"b5_212","first-page":"135","volume":"39","author":"Haskell DS","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"b6_213","volume-title":"A monograph of recent clinical studies","author":"Friedel RO","year":"1975"},{"issue":"16","key":"b7_214","first-page":"25","volume":"59","author":"Settle EC","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"b8_215","first-page":"119","volume":"54","author":"Montgomery SA","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"b9_216","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199409000-00001"},{"key":"b10_217","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb10136.x"},{"key":"b11_218","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199410000-00006","volume":"14","author":"Shrivastava RK","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"b12_219","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.v60n0105","volume":"60","author":"Silverstone PH","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"b13_220","doi-asserted-by":"crossref","unstructured":"13.JT Haskins, L Aguiar, A Pallay, and for the Venlafaxine XR 210 Study Group , et al. Double-blind, placebo-controlled study of once daily venlafaxine XR in outpatients with generalized anxiety disorder (abstract) . Presented at the 11th Congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80465-3"},{"key":"b14_221","doi-asserted-by":"crossref","unstructured":"14.JT Haskins, R Rudolph, L Aguiar, and for the Venlafaxine XR 210 Study Group , et al. Double-blind, placebo-controlled study of once daily venlafaxine XR in outpatients with generalized anxiety disorder (abstract) . Presented at the 11th Congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80465-3"},{"key":"b15_222","doi-asserted-by":"crossref","unstructured":"15.JT Haskins, R Rudolph, L Aguiar, and for the Venlafaxine XR 218 Study Group , et al. Venlafaxine XR is an efficacious short- and long-term treatment for generalized anxiety disorder (abstract) . Presented at the 11th Congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France.","DOI":"10.1016\/S0924-977X(98)80488-4"},{"key":"b16_223","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0009-9236(97)90198-3","volume":"61","author":"Modell JG","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"b17_224","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4088\/JCP.v58n1204","volume":"58","author":"Kavoussi RJ","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"b18_225","first-page":"4","volume":"52","author":"Richelson E.","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"b19_226","first-page":"256","volume":"50","author":"Davidson J.","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"b20_227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/S0007125000298978","volume":"153","author":"Munro A.","year":"1988","journal-title":"Br J Psychiatry"},{"key":"b21_228","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/070674378202700504","volume":"27","author":"Munro A","year":"1982","journal-title":"Can J Psychol"},{"key":"b22_229","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0190-9622(83)80106-6","volume":"9","author":"Bishop ER","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"b23_230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0190-9622(08)80767-0","volume":"22","author":"Damiani JT","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"b24_231","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/00015555625558","volume":"62","author":"Hamann K","year":"1982","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"b25_232","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.146.4.554","volume":"146","author":"Holmes VF","year":"1989","journal-title":"Am J Psychiatry"},{"key":"b26_233","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2340\/0001555565267270","volume":"65","author":"Lindskov R.","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"b27_234","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(93)70284-Z","volume":"29","author":"Driscoll MS","year":"1993","journal-title":"JAAD"},{"key":"b28_235","unstructured":"28.AF Schatzberg, JO Cole, and C. DeBattista, Manual of clinical psychopharmacology , 3rd edn. Washington DC: APA Press, 1997 : 154 -155 ."},{"key":"b29_236","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0193-953X(18)30179-5","volume":"16","author":"Meltzer HY","year":"1993","journal-title":"Psychiatr Clin North Am"},{"key":"b30_237","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(91)90030-U"},{"key":"b31_238","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/17.2.289","volume":"17","author":"Gerlach J.","year":"1991","journal-title":"Schizophr Bull"},{"key":"b32_239","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"Davis KL","year":"1991","journal-title":"Am J Psychiatry"},{"key":"b33_240","first-page":"13","volume":"54","author":"Lieberman JA","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"b34_241","first-page":"40S","volume":"57","author":"Casey DE","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"b35_242","volume-title":"Risperdal (risperidone)","year":"1996"},{"key":"b36_243","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2190\/JJY8-P3YW-MN9Y-WBTX","volume":"27","author":"De Leon OA","year":"1997","journal-title":"Int J Psychiatry Med"},{"key":"b37_244","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/schbul\/23.4.567","volume":"23","author":"Hansen TE","year":"1997","journal-title":"Schizophr Bull"},{"issue":"14","key":"b38_245","first-page":"39","volume":"58","author":"Leonard HL","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"13","key":"b39_246","first-page":"9","volume":"58","author":"Rasmussen SA","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"b40_247","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.32.6.671","volume":"32","author":"Watson CP","year":"1982","journal-title":"Neurology"},{"key":"b41_248","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.38.9.1427","volume":"38","author":"Max MB","year":"1988","journal-title":"Neurology"},{"key":"b42_249","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90128-X"},{"key":"b43_250","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.288.6415.436","volume":"288","author":"Feinmann C","year":"1984","journal-title":"Br Med J"},{"key":"b44_251","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(86)90041-2"},{"key":"b45_252","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000118429","volume":"19","author":"Eberhard G","year":"1988","journal-title":"Neuropsychobiology"},{"key":"b46_253","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0190-9622(81)70120-8","volume":"5","author":"Bernstein JE","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"b47_254","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.115.3.313"},{"key":"b48_255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1472-8206.1990.tb00482.x","volume":"4","author":"Figueiredo A","year":"1990","journal-title":"Fund Clin Pharmacol"},{"key":"b49_256","first-page":"17","volume":"65","author":"Lawlor F","year":"1990","journal-title":"Zeitschrift fur Hautkrankheiten"},{"key":"b50_257","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/clpt.1990.33","volume":"47","author":"Kishore-Kumar R","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"b51_258","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199206005-00001","volume":"6","author":"Boyer WI","year":"1992","journal-title":"Int J Clin Psychopharmacol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2008.00172.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2008.00172.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:31:19Z","timestamp":1708662679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2008.00172.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1529-8019.2008.00172.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2008.00172.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}